STOCK TITAN

Himax to Showcase WiseEye Palm Vein Authentication Featuring On-Device AI and GDPR-Compliant Privacy at Sectech Sweden 2025

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
AI

Himax (Nasdaq: HIMX) will showcase its WiseEye™ ultralow power AI palm vein authentication at Sectech Sweden 2025 (Oct 14–15, 2025). WiseEye delivers contactless ID verification in under 100 milliseconds, a False Acceptance Rate (FAR) below 1%, and on-device AI processing to avoid biometric data storage. The palm vein module is proven in mass production, certified to PSA Level 2, and designed for embedded, battery-powered access control. Himax also unveiled a bimodal palm-vein + facial authentication suite for smart door locks and says its biometric portfolio is GDPR-compliant, targeting regulated European markets. Visit booth C6:47 (Stockholmsmässan) or contact HX_WISEEYE@himax.com.tw to arrange a demo.

Himax (Nasdaq: HIMX) presenterà il suo WiseEye™ di IA ultrabasso consumo per l'autenticazione della palma della vena in Sectech Sweden 2025 (14–15 oct 2025). WiseEye offre verifica dell'identità senza contatto in meno di 100 millisecondi, un tasso di rifiuto falso (FAR) inferiore all'1%, e l'elaborazione AI sul dispositivo per evitare l'archiviazione dei dati biometrici. Il modulo della vena della palma è stato provato in produzione di massa, certificato a PSA Level 2, e progettato per controllo di accesso embedded e alimentato a batteria. Himax ha anche presentato una suite bimodale palma-vena + viso per serrature intelligenti e afferma che il suo portafoglio biometrico è GDPR conforme, mirato ai mercati europei regolamentati. Visita lo stand C6:47 (Stockholmsmässan) o contatta HX_WISEEYE@himax.com.tw per concordare una demo.

Himax (Nasdaq: HIMX) mostrará su WiseEye™ de IA de consumo ultrabajo consumo para autenticación de palma de vena en Sectech Sweden 2025 (14–15 oct de 2025). WiseEye ofrece verificación de identidad sin contacto en menos de 100 milisegundos, un FAR (tasa de aceptación falsa) por debajo del 1%, y procesamiento de IA en el dispositivo para evitar el almacenamiento de datos biométricos. El módulo de vena de palma está probado en producción en masa, certificado a PSA Nivel 2, y diseñado para control de acceso empotrado y alimentado por batería. Himax también presentó una suite bimodal de palma-vena + facial para cerraduras inteligentes y dice que su portfolio biométrico es conforme al GDPR, orientado a mercados europeos regulados. Visite el stand C6:47 (Stockholmsmässan) o contacte a HX_WISEEYE@himax.com.tw para coordinar una demostración.

Himax (나스닥: HIMX)는 Sectech Sweden 2025(2025년 10월 14–15일)에서 WiseEye™ 초저전력 AI 손바닥 정맥 인증을 선보일 예정입니다. WiseEye는 비접촉식 신원 확인을 100밀리초 미만에 제공합니다, FA(R) 1% 미만의 허용 오인율, 그리고 생체 데이터 저장을 피하기 위한 디바이스 내 AI 처리 기능을 제공합니다. 손바닥 정맥 모듈은 양산에서 검증되었으며, PSA Level 2 인증을 받았고, 임베디드형 배터리 구동 액세스 제어에 설계되어 있습니다. HIMAX는 또한 스마트 도어 잠금용 손바닥 정맥 + 얼굴 이중 모드 인증 스위트를 공개했고, 그들의 생체인식 포트폴리오가 GDPR 준수임을 밝히며 규제된 유럽 시장을 목표로 한다고 말합니다. 부스 번호 C6:47(Stockholmsmässan)을 방문하거나 DEMO를 예약하려면 HX_WISEEYE@himax.com.tw로 연락하십시오.

Himax (Nasdaq : HIMX) présentera son WiseEye™ IA ultrabasse consommation pour l'authentification par veine palmaire lors du Sectech Sweden 2025 (14–15 oct. 2025). WiseEye offre une vérification d'identité sans contact en moins de 100 millisecondes, un Taux d'acceptation falsifiée (FAR) inférieur à 1%, et un traitement IA sur l'appareil pour éviter le stockage des données biométriques. Le module de veine palmaire est en production de masse, certifié PSA Niveau 2, et conçu pour le contrôle d'accès embarqué et alimenté par batterie. Himax a également dévoilé une suite d'authentification bimodale paume-veine + visage pour les serrures intelligentes et affirme que son portefeuille biométrique est conforme au RGPD, ciblant les marchés européens réglementés. Visitez le stand C6:47 (Stockholmsmässan) ou contactez HX_WISEEYE@himax.com.tw pour organiser une démonstration.

Himax (Nasdaq: HIMX) wird auf der Sectech Sweden 2025 (14.–15. Okt. 2025) seine WiseEye™ Ultra-niedrig-Energie-KI-Palm-Verifizierungs-Lösung vorstellen. WiseEye bietet berührungslosen Identitätsnachweis in weniger als 100 Millisekunden, eine False Acceptance Rate (FAR) unter 1% und eine On-Device-KI-Verarbeitung, um biometrische Daten nicht zu speichern. Das Palm-Vein-Modul ist in der Massenproduktion bewährt, zertifiziert nach PSA Level 2, und für eingebettete, batteriebetriebene Zugangskontrolle ausgelegt. Himax hat auch eine bimodale Palmvenen- + Gesichtserkennung-Suite für intelligente Türschlösser vorgestellt und sagt, dass sein biometrisches Portfolio GDPR-konform ist und sich an regulierte europäische Märkte richtet. Besuchen Sie den Stand C6:47 (Stockholmsmässan) oder kontaktieren Sie HX_WISEEYE@himax.com.tw, um eine Demo zu vereinbaren.

Himax (Nasdaq: HIMX) سيعرض WiseEye™ AI منخفض الطاقة للغاية للمصادقة على عظام راحة اليد في Sectech Sweden 2025 (14–15 أكتوبر 2025). يوفّر WiseEye التحقق من الهوية بدون لمس خلال أقل من 100 مللي ثانية، ومعدل قبول كاذب (FAR) أقل من 1%، ومعالجة AI على الجهاز لتجنب تخزين البيانات البيومترية. وحدة وريد راحة اليد مثبتة في الإنتاج الضخم، وشهادة PSA المستوى 2، ومصممة للتحكم في الوصول المدمج المعتمد على البطاريات. كما كشفت Himax أيضًا عن حزمة مصادقة bimodal لليد-وريد + الوجه لقفل الباب الذكي وتقول إن محفظتها البيومترية متوافقة مع GDPR، وتستهدف الأسواق الأوروبية المنظمة. زوروا الجناح C6:47 (Stockholmsmässan) أو اتصلوا بـ HX_WISEEYE@himax.com.tw لترتيب عرض توضيحي.

Himax (纳斯达克: HIMX) 将在 Sectech Sweden 2025(2025年10月14–15日)展示其 WiseEye™ ultralow power AI 掌掌静脉认证。 WiseEye 提供 无接触身份验证在 100 毫秒内完成误识率 FAR 低于 1%,以及在设备端进行 AI 处理以避免生物识别数据存储。 掌静脉模组已在大规模生产中得到验证,获认证为 PSA Level 2,并为嵌入式、由电池供电的出入控制设计。 Himax 还揭示了一个 双模态 palm-vein + 面部 身份验证套件,适用于智能门锁,并表示其生物识别产品组合符合 GDPR,面向受监管的欧洲市场。 请访问展位 C6:47(Stockholmsmässan)或联系 HX_WISEEYE@himax.com.tw 安排演示。

Positive
  • Verification under 100 milliseconds
  • False Acceptance Rate below 1%
  • On-device AI eliminates biometric data storage
  • Certified to PSA Level 2 security
  • Proven in mass production
  • Bimodal palm vein + facial option for smart locks
Negative
  • None.

Insights

Himax presents a low‑power, on‑device palm vein module with fast matching (<100ms) and a reported FAR below 1%, aimed at access control.

The product operates by running AI models locally on endpoint hardware to perform palm vein recognition in under 100 milliseconds, which supports contactless, high‑speed authentication and claims mass‑production readiness for embedded devices like smart door locks. The module’s PSA Level 2 certification and stated deployment in production devices indicate a focus on device integrity and supply readiness rather than an experimental prototype.

Key dependencies include integration with customer hardware, power budget for battery‑powered locks, and real‑world false acceptance/rejection rates versus the advertised 1%. Watch for technical validation at the show on Oct. 14-15, 2025 and any published interoperability or power-consumption metrics within the next 3–12 months.

The solution emphasizes on‑device AI and GDPR compliance to minimize biometric data exposure, improving adoption in regulated markets.

By performing recognition entirely on endpoint devices and asserting GDPR compliance, the design reduces centralized biometric storage risks and aligns with privacy expectations for Europe. The claim of eliminating biometric data storage and PSA Level 2 certification bolster privacy and security assertions, but auditors will seek documentation and implementation details to confirm legal compliance in specific deployments.

Monitor published technical whitepapers, certification artifacts, and any customer deployment case studies over the next 6–12 months to verify the GDPR and PSA claims and to confirm that on‑device processing meets regulatory audit requirements.

Featuring Privacy-first, Ultralow Power AI Biometric Innovations to Enable Secure, Contactless, High-Speed Authentication for Next-Generation Access Control Applications

TAINAN, Taiwan, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (“Himax” or the “Company”) (Nasdaq: HIMX), a leading provider of fabless display driver ICs and other semiconductor solutions, has announced it will showcase its WiseEye™ ultralow power AI technology spotlighting its palm vein authentication capabilities at Sectech Sweden 2025, an exhibition event focused on security solutions, taking place from Oct. 14 -15, 2025 in Sweden.

WiseEye™ palm vein authentication delivers a contactless and hygienic user experience, enabling rapid identity verification in under 100 milliseconds. It features industry-leading performance with a False Acceptance Rate (FAR) below 1% and superior liveness detection accuracy, making it ideal for seamless integration into diverse access control environments. Built on a privacy-first architecture, WiseEye employs on-device AI to perform real-time palm vein recognition entirely on endpoint devices, eliminating biometric data storage and ensuring maximum privacy and user trust. Moreover, Himax’s biometric authentication portfolio complies with Europe’s General Data Protection Regulation (GDPR), one of the world’s most stringent data privacy laws, ensuring strong privacy protection and enabling adoption in highly regulated markets. Proven in mass production across a wide range of access control devices, the WiseEye PalmVein Module offers a compact, lightweight, and secure embedded biometric solution with strong privacy protection. The module is certified to PSA (Platform Security Architecture) Level 2, attesting to its compliance with rigorous industry security standards.

During the event, Himax will also unveil its expanded biometric suite, a bimodal authentication solution combining palm vein and facial recognition, meticulously designed to meet customer demand for greater flexibility in smart door locks under all environmental conditions. By integrating two biometric modalities, it enhances both security and user convenience, representing a significant breakthrough in biometric technology for battery-powered smart devices.

Himax invites all interested parties to stop by our exhibition booth at C6:47 (Stockholmsmässan, Älvsjö, Sweden) to experience the future of biometric authentication firsthand. To schedule a meeting or booth tour, please contact Himax at HX_WISEEYE@himax.com.tw.

About Himax Technologies, Inc.

Himax Technologies, Inc. (NASDAQ: HIMX) is a leading global fabless semiconductor solution provider dedicated to display imaging processing technologies. The Company’s display driver ICs and timing controllers have been adopted at scale across multiple industries worldwide including TVs, PC monitors, laptops, mobile phones, tablets, automotive, ePaper devices, industrial displays, among others. As the global market share leader in automotive display technology, the Company offers innovative and comprehensive automotive IC solutions, including traditional driver ICs, advanced in-cell Touch and Display Driver Integration (TDDI), local dimming timing controllers (Local Dimming Tcon), Large Touch and Display Driver Integration (LTDI) and OLED display technologies. Himax is also a pioneer in tinyML visual-AI and optical technology related fields. The Company’s industry-leading WiseEyeTM Ultralow Power AI Sensing technology which incorporates Himax proprietary ultralow power AI processor, always-on CMOS image sensor, and CNN-based AI algorithm has been widely deployed in consumer electronics and AIoT related applications. Himax optics technologies, such as diffractive wafer level optics, LCoS microdisplays and 3D sensing solutions, are critical for facilitating emerging AR/VR/metaverse technologies. Additionally, Himax designs and provides touch controllers, OLED ICs, LED ICs, EPD ICs, power management ICs, and CMOS image sensors for diverse display application coverage. Founded in 2001 and headquartered in Tainan, Taiwan, Himax currently employs around 2,200 people from three Taiwan-based offices in Tainan, Hsinchu and Taipei and country offices in China, Korea, Japan, Germany, and the US. Himax has 2,586 patents granted and 371 patents pending approval worldwide as of September 30, 2025.

http://www.himax.com.tw

Forward Looking Statements

Factors that could cause actual events or results to differ materially from those described in this conference call include, but are not limited to, the effect of the Covid-19 pandemic on the Company’s business; general business and economic conditions and the state of the semiconductor industry; market acceptance and competitiveness of the driver and non-driver products developed by the Company; demand for end-use applications products; reliance on a small group of principal customers; the uncertainty of continued success in technological innovations; our ability to develop and protect our intellectual property; pricing pressures including declines in average selling prices; changes in customer order patterns; changes in estimated full-year effective tax rate; shortage in supply of key components; changes in environmental laws and regulations; changes in export license regulated by Export Administration Regulations (EAR); exchange rate fluctuations; regulatory approvals for further investments in our subsidiaries; our ability to collect accounts receivable and manage inventory and other risks described from time to time in the Company's SEC filings, including those risks identified in the section entitled "Risk Factors" in its Form 20-F for the year ended December 31, 2024 filed with the SEC, as may be amended.

Company Contacts:

Karen Tiao, Head of IR/PR
Himax Technologies, Inc.
Tel: +886-2-2370-3999
Fax: +886-2-2314-0877
Email: hx_ir@himax.com.tw
www.himax.com.tw

Mark Schwalenberg, Director
Investor Relations - US Representative
MZ North America
Tel: +1-312-261-6430
Email: HIMX@mzgroup.us
www.mzgroup.us


FAQ

What will Himax (HIMX) present at Sectech Sweden 2025 on Oct 14–15, 2025?

Himax will showcase the WiseEye palm vein authentication and an expanded bimodal palm‑vein + facial suite at booth C6:47.

How fast is WiseEye palm vein authentication from Himax (HIMX)?

WiseEye performs contactless identity verification in under 100 milliseconds.

What accuracy and security metrics does Himax (HIMX) report for WiseEye palm vein?

Himax reports a False Acceptance Rate below 1% and PSA Level 2 certification for the module.

Is Himax's (HIMX) WiseEye palm vein solution GDPR compliant for European deployment?

Himax states the biometric portfolio is designed to comply with GDPR and uses on‑device AI to avoid storing biometric data.

Can WiseEye be used in battery-powered smart door locks from Himax (HIMX)?

Yes—Himax positions the ultralow power WiseEye and the bimodal suite for integration into battery‑powered smart locks.

How can investors or customers schedule a demo of Himax (HIMX) WiseEye at Sectech?

Visit booth C6:47 at Stockholmsmässan or contact HX_WISEEYE@himax.com.tw to arrange a meeting or booth tour.
Himax Technologi

NASDAQ:HIMX

HIMX Rankings

HIMX Latest News

HIMX Latest SEC Filings

HIMX Stock Data

1.66B
120.15M
31.07%
19.9%
3.4%
Semiconductors
Technology
Link
Taiwan
Tainan City